Director dealings: Genedrive CEO raises stake

1st Sep 2026 12:14

(Sharecast News) - Genedrive revealed on Tuesday that chief executive Gino Miele had acquired 700,000 ordinary shares in the AIM-listed pharmacogenetic testing company.

Miele, who took over as CEO in August 2024, purchased the shares at an average price of 1.38p each, for a total value of £9,660.

Following the purchase, Miele holds a beneficial interest in 7.9m ordinary Genedrive shares, representing approximately 0.49% of the company's issued share capital.

As of 1415 BST, Genedrive shares were up 7.14% at 1.50p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Staffline Group (STAF)

Director name: Spain,Thomas

Amount purchased: 75,249 @ 42.00p

Value: £31,604.58

Genedrive (GDR)

Director name: Miele,Gino

Amount purchased: 700,000 @ 1.38p

Value: £9,660.00

Invesco Bond Income Plus Limited Npv (BIPS)

Director name: Kumar ,Arun

Amount purchased: 2,757 @ 170.74p

Value: £4,707.30

Top Director Sells

Staffline Group (STAF)

Director name: Spain,Thomas

Amount sold: 75,249 @ 42.00p

Value: £31,604.58